Cart
sales@molnova.com
MBP (68-82), guinea pig
CAS No. 98474-59-0
MBP (68-82), guinea pig( —— )
Catalog No. M29791 CAS No. 98474-59-0
Myelin Basic Protein (68-82), guinea pig, is a peptide with the sequence Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn.Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 87 | In Stock |
|
| 5MG | 132 | In Stock |
|
| 10MG | 205 | In Stock |
|
| 25MG | 350 | In Stock |
|
| 50MG | 516 | In Stock |
|
| 100MG | 734 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
Biological Information
-
Product NameMBP (68-82), guinea pig
-
NoteResearch use only, not for human use.
-
Brief DescriptionMyelin Basic Protein (68-82), guinea pig, is a peptide with the sequence Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn.Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).
-
DescriptionMyelin Basic Protein (68-82), guinea pig, is a peptide with the sequence Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn.Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number98474-59-0
-
Formula Weight1736.79
-
Molecular FormulaC71H113N23O28
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 50 mg/mL (28.79 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Baldrinal
Baldrinal, valtrate, and acevaltrate are the quality control compounds of Valeriana jatamansi Jones.
-
EAAT2 activator 1
F2005-0304 is a thiopyridazine derivative that has been found to increase EAAT2 protein levels in astrocytes.
-
OGT inhibitor 4a
OGT inhibitor 4a is an O-linked n-acetylglucosaminyltransferase (OGT) inhibitor with anticancer activity for the study of autoimmune and neurological disorders.
